Considering anti-PD-1 Ab lost its efficacy to suppress tumor growth under the CR condition along with the alteration of CD8+ T cells’ mitochondrial activity, the energy restricted physical condition in cancer patients may impair CD8+ T cell immune surveillance and the efficacy of immunotherapy. The gene discussed is CD8A; the disease is cancer.